Reg IV Antibodies

Santa Cruz Biotechnology offers a broad range of Reg IV monoclonal antibodies for investigating Reg IV's role in various biological processes. Reg IV Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Reg IV, also known as regenerating islet-derived protein IV, plays a crucial role in cellular regeneration and repair, particularly in the gastrointestinal tract. Research has shown that Reg IV is involved in inflammation and tissue remodeling processes. Reg IV expression patterns have been linked to various cancers and other diseases, making it an important focus for biomedical research. Scientists studying Reg IV can gain valuable insights into its potential as a biomarker for disease progression. Understanding Reg IV's molecular mechanisms can lead to the development of targeted therapeutic strategies. Ongoing research continues to reveal new functions of Reg IV in cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Reg IV's role in health and disease.